Evidence map›Paper›PMID 14688106›Full record

ArticleInfection and immunity2004

Immunogenicity of gonococcal transferrin binding proteins during natural infections.

Gregory A Price, Marcia M Hobbs, Cynthia Nau Cornelissen

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Clinical microbiology reviews · 2024
    Review
  2. Article
  3. Recent Progress Towards a Gonococcal Vaccine.Frontiers in cellular and infection microbiology · 2022
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Extragenital manifestations of Neisseria gonorrhoeae.Current infectious disease reports · 2006
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gregory A PriceDepartment of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298-0678, USA.
Marcia M Hobbs
Cynthia Nau Cornelissen
Virginia Commonwealth University Medical Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Trichomonas Typing SystemU19AI031496 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SPARLING, PHILIP FREDERICK · 1995 to 2014
$24.9M
A MOLECULAR STUDY OF THE GONOCOCCAL TRANSFERRIN RECEPTORR01AI047141 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CORNELISSEN, CYNTHIA N · 2001 to 2010
$3.1M
THE EPIDEMIOLOGY OF STDS IN RURAL NORTH CAROLINAU01AI031496 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SPARLING, PHILIP FREDERICK · 1991 to 1994
–
NIAID NIH HHS AI31496NIAID NIH HHS AI47141NIAID NIH HHS R01 AI047141NIAID NIH HHS U19 AI031496
6 · The paper itself

Abstract

In this study, we examined the immune response during gonococcal infection to the individual transferrin binding proteins by using a quantitative enzyme-linked immunosorbent assay (ELISA). Recombinant transferrin binding protein A (rTbpA) and rTbpB were purified under nondenaturing conditions for use as ELISA antigens. Sera and secretions from culture-positive individuals were analyzed for antibodies to rTbpA and rTbpB and compared to samples from individuals with no history of gonococcal infection. Although antibodies to both rTbpA and rTbpB were detected in serum, in most cases the antibody levels were not significantly different from those measured in the control population. Also, previous history of gonococcal infection did not increase antibody levels in serum, suggesting the lack of an anamnestic response. Analysis of secretion samples revealed antibody levels that were generally below the limits of detection in our assay. Overall, this study demonstrated a paucity of systemic and local antibody responses to rTbps as a result of natural infection and represents a baseline over which a protective antibody response will have to be generated in order to develop an efficacious gonococcal vaccine.

Indexed as

Antibodies, BacterialAntigens, BacterialCervix MucusFemaleGonorrheaHumansImmunoglobulinsMaleNeisseria gonorrhoeaeSemenTransferrin-Binding Protein ATransferrin-Binding Protein BAntibodies, BacterialAntigens, BacterialImmunoglobulinsTransferrin-Binding Protein ATransferrin-Binding Protein B

Identifiers

PMID14688106
PMCPMC343986
OpenAlexW2166295301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.